A

Details for Australian Trade Mark No. 904037 (hide)

Owner Otsuka Pharmaceutical Co., Ltd.

Service Spruson & Ferguson

Various Convention priority claimed: 9 January 2002, United States of America, No. 78/101714 in respect of PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT AND PREVENTION OF CARDIOVASCULAR DISEASES, CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS, STROKE, CANCER, INFL

Classes

Class 5 Pharmaceutical preparations for human use

Event Publications

13 September 2007 Subsequent Owners/Holder Registered - Full Assignment

  Bristol-Myers Squibb Company a Delaware corporation is the full asignee of Otsuka Pharmaceutical Co. Ltd..

18 October 2007 Registrations/Protected IR Name Amendment and Changes

  The owner's/holder's name has been changed to Otsuka Pharmaceutical Co., Ltd..

2 February 2012 Renewal of Registration/IR

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the ATMOSS Australian Trade Mark On-line Search System.

Next and Previous Trademarks/Applications

904038-WINE AWAY

904036-SWEATEQUITY ; SWEAT EQUITY